An injection device is disclosed which comprises a housing (140, 240, 440, 740) for a plurality of cartridges (110,310,410,810) each containing a medicament to be administered to a patient. A plurality of needles (120, 220, 320, 420, 720, 820) may be provided in communication with the plurality of cartridges. A delivery mechanism is arranged to deliver medicament through the plurality of cartridges via the plurality of needles. An injection device may comprise a drive member (130) having a cam surface (136) configured to engage a surface of a carrier (150) and rotate the carrier about a pivot (152) and at least one plunger (134) arranged to engage a cylinder in the cartridge.

A device for percutaneous delivery of therapeutic agents includes a first wheel having an axis of rotation, a first axial surface rotably mounted on the head, a second axial surface, an outer surface, and a plurality of needles disposed upon the outer surface, each needle having a tip projecting away from the axis of rotation of the wheel. The device includes a second wheel having an axis of rotation, a first axial surface affixed to the second axial surface of the first wheel, a second axial surface, an outer surface, and a plurality of needles disposed upon the outer surface, each needle having a tip projecting away from the axis of rotation.

Embodiment provided herein are directed to microneedle patches for agent application on a mammal skin. The microneedle patch may comprise a patch scaffold having a surface, and a plurality of microneedles disposed on the surface. Each of the microneedles may be capable of piercing the skin 50 μm to 1000 μm deep, and comprises a composite material comprising polyvinylpyrrolidone (PVP) and one or more additional copolymers selected from the group consisting of maltose, leucine, and dileucine.

The embodiments relate to improved skin quality, health and appearance using a new delivery method and certain bioactive compositions and formulations. The system incorporates microneedle delivery technology with unique compositions and formulations. Such development allows for the pursuit of personalized medicine, or treatment delivery that can expand to remote controlled environment, immediate compounding and ultimate personalization with a state of the art longitudinal data predictive analytics. Certain formulations described herein are unique, combinatory and synergistic. Secured by high-tech proprietary system, there are unlimited potentials using AQT technology including but not limited to 3-D printing of a biodegradable micro chips that can be delivered via injection, AQT or any other possible route.

The present invention provides a needle unit (10, 310, 410, 510) having a proximal space (13, 513) adapted to accommodate a portion of a variable volume reservoir, the needle unit (10, 310, 410, 510) comprising: a needle carrier (15, 315, 415, 515), a needle tube (21, 121, 221, 321, 421, 521) being fixed to the needle carrier (15, 315, 415, 515) and comprising a distal needle end (23, 123, 223, 323, 423, 523) for providing fluid communication to an injection site, a needle shield (50, 350, 450, 550) carrying a sealed chamber (38, 138, 238, 338, 438, 538) for accommodating a distal portion of the needle tube (21, 121, 221, 321, 421, 521), the sealed chamber (38, 138, 238, 338, 438, 538) being sealed distally by a penetrable self-sealing septum (39, 139, 239, 339, 439, 539), and a flow channel (24, 124, 224, 324, 424, 524) for establishing fluid communication between the sealed chamber (38, 138, 238, 338, 438, 538) and the proximal space (13, 513), wherein the needle shield (50, 350, 450, 550) and the needle carrier (15, 315, 415, 515) are capable of relative motion between a first relative position in which the sealed chamber (38, 138, 238, 338, 438, 538) houses the distal needle end (23, 123, 223, 323, 423, 523), and a second relative position in which the distal needle end (23, 123, 223, 323, 423, 523) protrudes from the sealed chamber (38, 138, 238, 338, 438, 538) through the penetrable self-sealing septum (39, 139, 239, 339, 439, 539), and wherein the needle tube (21, 121, 221, 321, 421, 521) further comprises a side hole (25, 125, 225, 325, 425, 525), the side hole (25, 125, 225, 325, 425, 525) being in fluid communication with the flow channel (24, 124, 224, 324, 424, 524) and positioned within the sealed chamber (38, 138, 238, 338, 438, 538) when the needle shield (50, 350, 450, 550) and the needle carrier (15, 315, 415, 515) are in the second relative position.

An attachable needle assembly (102) for use on a medication delivery pen (104), the needle assembly (102) comprising a housing (1 10) enclosing a hub (106) having a communication needle (108) configured to engage the medication delivery pen (104) and pierce a reservoir septum of the medication delivery pen (104), a communication septum (172, 176) of the needle assembly (102) defining a septum chamber (180, 182) that is in fluid communication with the communication needle (108), a plurality of needles (118) disposed in the communication septum (172, 176), a follower ring (130) that determines which needle (124) of the plurality of needles (118) is to be selected, and a snap ring (136) that exposes the selected needle (124) and moves the selected needle (124) in fluid communication with the septum chamber (180, 182), wherein when the housing (110) is in a first position, the plurality of needles (118) is not exposed, and when the housing (110) is in a second position, the selected needle (124) is in fluid communication with the septum chamber (180, 182) and exposed for medicament delivery.

An attachable needle assembly (2) used on a medication delivery pen (4), the needle assembly (2) comprising a spike (9) configured to pierce a vial, reservoir or cartridge septum of the pen (4), a needle guide (12) configured to mate with the pen (4), the needle guide (12) enclosing a septum (22) of the needle assembly (2) defining a septum chamber (31), the septum chamber (31) being in fluid communication with the spike (9), a plurality of needles (34) disposed in the septum (22) of the needle assembly (2), a sterility barrier (60) enclosing each of the plurality of needles (34), each of a plurality of sterility barriers (60) having a peel tab (70), each of a plurality of peel tabs (70) being wrapped around the needle guide (12), wherein when one of the plurality of needles (40) is drawn from the needle guide (12) from a first position to a second position, the needle (40) fluidly communicates with the septum chamber (31), and the sterility barrier (60) and the peel tab (70) of the needle (40) are removed.

Provided is an auxiliary tool that makes skin administration of a micro-needle array on which a large number of micro-needles are provided as a result of a progress in fine processing technology more certain. A skin tight-binding device provided with a tight-binding band, and a hole provided on the tight-binding band, in which, when the tight-binding band is fixed to skin, the hole forms a micro-needle patch administration portion, and the skin tight-binding device further provided with a fixing tool that fixes the tight-binding band to the skin.

Systems, instruments, methods, and compositions are described involving removing a portion of the epidermis within a donor site on a subject, and harvesting dermal plugs within the donor site. An injectable filler is formed by mincing the dermal plugs. The injectable filler is configured for injecting into a recipient site on the subject.

An automatic injection control device injects fluid at a rate directly related to the displacement rate of the device body from a held positioning member. The device has a syringe end, a gripping end, a syringe barrel coupled to the body and a refillable reservoir and at least one directional valve at the syringe end of the body. The directional valves permitting refilling of the refillable reservoir without removing the syringe barrel. Also, a transmission system is coupled to the body, as well as the positioning member, a syringe plunging member, and a gearing mechanism linking the positioning member to the syringe plunging member. The device is designed so that when the positioning member is held in a fixed extended position and the body is pulled by the gripping end, the transmission system provides a one-way motion of the syringe plunging member to precisely inject fluid from the device.